Adrabetadex Uses, Dosage, Side Effects and more
Adrabetadex is under investigation in clinical trial NCT03887533 (Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1).
| Trade Name | Adrabetadex |
| Generic | Adrabetadex |
| Adrabetadex Other Names | Adrabetadex |
| Type | |
| Formula | C54H94O38 |
| Weight | Average: 1351.308 Monoisotopic: 1350.542308587 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
